In contrast to the PreDM phase, in which negative trends in AIP and HbA1c were somewhat more pronounced, in T2DM, irisin variation seems less closely associated with the lipid profile, possibly reflecting a loss of irisin’s compensatory function as insulin resistance and adipocyte dysfunction worsen. The gene discussed is INS; the disease is type 2 diabetes mellitus.